13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-13, with 40 holding rows worth $178,823,000.
- Accession
- 0001493152-16-009777
- Filer
- CIK 1582844
- Filed
- 2016-05-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2016
A holdings report, 40 entries on the cover page, a total value of $178,823,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $178,823,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,500,000 | $21,125,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 2,736,642 | $14,778,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 5,526,172 | $13,815,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 2,500,000 | $12,700,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 826,799 | $11,674,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 623,631 | $11,568,000 | thousands by filing date | |
| RRSAT GLOBAL COMM NTWRK LTD | M8183P102 | SHS | 608,318 | $7,945,000 | thousands by filing date | |
| CYNAPSUS THERAPEUTICS INC | 23257Y859 | COM PAR NO PAR | 590,530 | $7,027,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 657,670 | $6,721,000 | thousands by filing date | |
| iShares Russell 2000 ETF | 464287655 | SHS | 50,000 | $5,532,000 | thousands by filing date | put |
| CELATOR PHARMACEUTICALS INC | 15089R102 | Cmn | 500,000 | $5,515,000 | thousands by filing date | |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 544,972 | $4,883,000 | thousands by filing date | |
| EVERYDAY HEALTH INC COM | 300415106 | Stock | 824,500 | $4,617,000 | thousands by filing date | |
| STRONGBRIDGE BIOPHARMA PLC | G85347105 | SHS USD | 1,063,747 | $4,506,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 2,678,753 | $3,804,000 | thousands by filing date | |
| UNIVERSAL DISPLAY CORP | 91347P105 | COM | 70,000 | $3,787,000 | thousands by filing date | |
| CEMPRA INC | 15130J109 | COM | 210,000 | $3,679,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 385,100 | $3,524,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 386,308 | $3,481,000 | thousands by filing date | |
| INNOCOLL HLDGS PLC | G4783X105 | SHS | 377,765 | $3,241,000 | thousands by filing date | |
| IGI LABORATORIES INC | 449575AB5 | NOTE 3.75012/1 | 4,000,000 | $3,190,000 | thousands by filing date | principal |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 308,044 | $3,053,000 | thousands by filing date | |
| RETROPHIN INC | 761299106 | COM | 200,000 | $2,732,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 103,283 | $2,210,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907AK4 | NOTE 4.750 2/1 | 3,000,000 | $2,108,000 | thousands by filing date | principal |
| ALIMERA SCIENCES INC | 016259103 | COM | 974,318 | $1,705,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 776,842 | $1,616,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H104 | COM | 467,333 | $1,524,000 | thousands by filing date | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 165,368 | $1,406,000 | thousands by filing date | |
| EXELIXIS INC COM | 30161Q104 | Stock | 320,897 | $1,284,000 | thousands by filing date | |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 232,800 | $1,015,000 | thousands by filing date | |
| ENDOLOGIX INC | 29266SAA4 | NOTE 2.250%12/1 | 796,000 | $581,000 | thousands by filing date | principal |
| AEGERION PHARMACEUTICALS INC | 00767EAB8 | NOTE 2.000 8/1 | 1,000,000 | $508,000 | thousands by filing date | principal |
| TELIGENT INC NEW | 87960W104 | COM | 103,411 | $507,000 | thousands by filing date | |
| CARDICA INC | 14141R309 | COM NEW | 120,958 | $431,000 | thousands by filing date | |
| MANNKIND CORP | 56400P201 | COM | 150,000 | $242,000 | thousands by filing date | put |
| SECOND SIGHT MED PRODS INC | 81362J100 | COM | 50,000 | $242,000 | thousands by filing date | put |
| AKARI THERAPEUTICS PLC | 00972G108 | ADR | 18,250 | $236,000 | thousands by filing date | |
| COMBIMATRIX CORPORATION | 20009T501 | COM PAR | 47,431 | $171,000 | thousands by filing date | |
| INVIVO THERAPEUTICS HLDGS CO | 46186M209 | COM NEW | 20,000 | $140,000 | thousands by filing date | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-16-009777 | this filing | 2016-05-13 | acceptance time not in the bulk data set |